Strategic Blueprint’s Asensus Surgical, Inc. ASXC Stock Holding History

Strategic Blueprint’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-24	Closed	–	–	1384
2021 Q2	$0	Buy	+24	New	+$60	﹤0.01%	1446

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Strategic Blueprint's ASXC Position: Q3 2021 in Review

Strategic Blueprint sold out of Asensus Surgical, Inc. (ASXC) in Q3 2021, closing a stake of 24 shares.

Strategic Blueprint first reported a position in ASXC in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 111 funds tracked by Wall St. Rank hold ASXC as of Q3 2021.

Strategic Blueprint reported no remaining Asensus Surgical, Inc. position as of Q3 2021 after selling out during the quarter.
Strategic Blueprint sold 24 Asensus Surgical, Inc. shares in Q3 2021.
Strategic Blueprint first reported a position in Asensus Surgical, Inc. in Q2 2021 and held it in 1 quarter.
Strategic Blueprint's Asensus Surgical, Inc. position peaked at $0 in Q2 2021.
111 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.